EP2917223

2-Setin sefem-efnasambönd

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    29.10.2013
  • EP published:
    16.1.2019
  • EP application number:
    13820853.3
  • Max expiry date:
    28.10.2033
  • Expiry date:
    28.10.2020
  • Title:
    2 SUBSTITUTED CEPHEM COMPOUNDS

Timeline

Today
29.10.2013EP application
16.1.2019EP Publication
27.3.2019Translation submitted
15.4.2019Registration published
28.10.2020Expires

Owner

  • Name:
    Glaxo Group Limited
  • Address:
    980 Great West Road, Brentford, Middlesex TW8 9GS, GB
  • Name:
    Shionogi & Co., Ltd
  • Address:
    1-8, Doshomachi 3 chome Chuo-Ku, 541-0045, Osaka, JP

Inventor

  • Name:
    LIAO, Xiangmin
  • Address:
    Collegeville, Pennsylvania, US
  • Name:
    PEARSON, Neil, David
  • Address:
    Collegeville, Pennsylvania, US
  • Name:
    PENDRAK, Israil
  • Address:
    Collegeville, Pennsylvania, US
  • Name:
    THALGI, Reema
  • Address:
    Collegeville, Pennsylvania, US
  • Name:
    YAMAWAKI, Kenji
  • Address:
    Toyonaka-shiOsaka, JP
  • Name:
    YOKOO, Katsuki
  • Address:
    Toyonaka-shiOsaka, JP
  • Name:
    SATO, Jun
  • Address:
    Toyonaka-shiOsaka, JP
  • Name:
    KUSANO, Hiroki
  • Address:
    Toyonaka-shiOsaka, JP
  • Name:
    AOKI, Toshiaki
  • Address:
    Toyonaka-shiOsaka, JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201261719523 P
  • Date:
    29.10.2012
  • Country:
    US

Classification

  • Categories:
    C07D 505/24, A61K 31/546, C07D 501/50

Annual fees

Number

Paid

Expires

Payer

Number: 7

Paid: 12.9.2019

Expires: 28.10.2020

Payer: Örn Þór, slf.

Upload documents